US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Warren Buffett holdings

2,433.79

-37.6689-1.52%

Number of Gainers:10

Number of Losers:31

Number of Flat:2

PE:- -

High:2,471.46

Open:2,471.46

Low:2,411.49

Close:2,471.46

Loading ...

2seventy Bio to be acquired by Bristol Myers for $5.00 per share in cash

CDs vs. High-Yield Savings Accounts: Which One Actually Makes You More Money?

A Tale of 2 AI Stocks: Why Broadcom Soared Even as "Baby Broadcom" Plunged Last Week

BUZZ-Genmab falls after J&J Hexabody opt-out

The Nasdaq Just Plunged 728 Points: 3 Must-See Statistics That Put This Move Into Perspective

Wall Street declines after new Trump tariffs on Canada

The West Australian

2seventy Bio to be Acquired by Bristol Myers Squibb

MT Newswires Live

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)

CORRECTED-ANALYSIS-If Europe builds the gigafactories, will an AI industry come?

ASX 200 crash playbook, pause or panic?

Ninety-nine red flags

BRIEF-2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside

Nasdaq Correction: Is This High-Yield Dividend Stock the Right Place to Run for Cover?

Lam Research Corporation (LRCX): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/BK4559/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4559"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4559\",,,,,undefined,":{"symbol":"BK4559","market":"US","secType":"PLATE","nameCN":"Warren Buffett holdings","latestPrice":2433.79,"timestamp":1741723199999,"preClose":2471.459,"halted":0,"volume":643124766,"delay":0,"changeRate":-0.015242,"change":-37.668945,"pbRate":6.512021,"amount":118503383888.08105,"amplitude":0.024262,"prevYearClose":2550.9072,"fiveDayClose":2530.3872,"twentyDayClose":2567.4453,"turnoverRate":0.00874,"marketCap":11926640016896,"floatMarketCap":11325746664832,"peRate":28.637082},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4559\",,,,,undefined,":{"symbol":"BK4559","high":2471.4568,"amplitude":0.024262,"preClose":2471.459,"low":2411.4946,"pbRate":"6.512021","latestPrice":2433.79,"volume":643124766,"delay":0,"open":2471.4568,"prevYearClose":2550.9072,"prevWeekClose":2533.5,"prevMonthClose":2602.9524,"prevQuarterClose":2550.9072,"fiveDayClose":2530.3872,"twentyDayClose":2567.4453,"sixtyDayClose":2583.0635,"secType":"PLATE","market":"US","turnoverRate":0.00874,"peRate":28.637082,"marketCap":11926640016896,"floatMarketCap":11325746664832,"timestamp":1741723199999,"nameCN":"Warren Buffett holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4559\",,,,undefined,":{"bkCode":"BK4559","up":10,"down":31,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4559\",pageSize:16,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518571573","title":"2seventy Bio to be acquired by Bristol Myers for $5.00 per share in cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2518571573","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518571573?lang=en_us&edition=fundamental","pubTime":"2025-03-11 17:50","pubTimestamp":1741686609,"startTime":"0","endTime":"0","summary":"2seventy Bio (TSVT) announced a definitive merger agreement under which Bristol Myers Squibb (BMY) will acquire all of the outstanding shares of 2s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/2seventy-bio-to-be-acquired-by-bristol-myers-for-5-00-per-share-in-cash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/2seventy-bio-to-be-acquired-by-bristol-myers-for-5-00-per-share-in-cash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0985481810.HKD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4559","LU2125154778.USD","LU0096364046.USD","LU1718418525.SGD","LU0237698245.USD","LU1032466523.USD","BK4126","BMY","BK4532","LU0306807586.USD","BK4139","LU1868836914.USD","LU1670711123.USD","MYE","LU0061475181.USD","LU2360032135.SGD","LU1670710588.SGD","LU2242652126.USD","LU1585245621.USD","LU0321505868.SGD","BK4588","IE00BJJMRZ35.SGD","LU0225284248.USD","BK4581","IE00BSNM7G36.USD","LU0225771236.USD","LU0456855351.SGD","LU0868494617.USD","IE0002141913.USD","LU1571399168.USD","LU2125154935.USD","BK4007","IE00BFTCPJ56.SGD","LU1868836591.USD","LU1868836757.USD","LU1093756168.USD","TSVT","IE00BFXG1179.USD","LU2133065610.SGD","LU1291159041.SGD","LU1261432733.SGD","LU1670711040.USD","LU1074936037.SGD","LU1868837136.USD","LU0882574055.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2518471871","title":"CDs vs. High-Yield Savings Accounts: Which One Actually Makes You More Money?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471871","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471871?lang=en_us&edition=fundamental","pubTime":"2025-03-11 17:30","pubTimestamp":1741685400,"startTime":"0","endTime":"0","summary":"CDs and high-yield savings accounts are both great places to keep your cash. Find out how your savings goals may determine which option makes you more money.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/money/banks/articles/cds-vs-high-yield-savings-accounts-which-one-actually-makes-you-more-money/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00BFSS8Q28.SGD","LU1674673428.USD","LU0211331839.USD","LU0868494708.USD","LU1674673691.USD","IE00B19Z3B42.SGD","LU0094547139.USD","LU0648001328.SGD","LU2361045086.USD","IE0004445015.USD","AXP","IE00BJJMRX11.SGD","LU2361044865.SGD","IE00B7KXQ091.USD","LU2461242641.AUD","LU1201861165.SGD","LU1917777945.USD","LU0211328371.USD","LU0980610538.SGD","BK4588","LU0130518102.USD","US6M.BOND","LU0477156953.USD","IE00B19Z3581.USD","US30Y.BOND","LU0477156797.USD","LU0942090050.USD","BK4559","IE00B4JS1V06.HKD","LU2361044949.HKD","LU0130517989.USD","IE0005OL40V9.USD","LU1267930490.SGD","US10Y.BOND","LU2360107671.USD","US2Y.BOND","US3Y.BOND","LU0868494617.USD","LU2106854487.HKD","IE00BFSS7M15.SGD","COF","LU0130102774.USD","US7Y.BOND","IE00B775H168.HKD","LU0648000940.SGD","LU1974910355.USD","LU0211327993.USD","US12M.BOND","LU0053666078.USD","US5Y.BOND"],"gpt_icon":0},{"id":"2518996267","title":"A Tale of 2 AI Stocks: Why Broadcom Soared Even as \"Baby Broadcom\" Plunged Last Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2518996267","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518996267?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:30","pubTimestamp":1741681800,"startTime":"0","endTime":"0","summary":"Broadcom and Marvell have similar businesses, but their stocks went in opposite directions last week.Customer concentration and valuation set the two apart.Here are the lessons investors can take away from last week's divergence.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/11/tale-of-two-ai-stocks-broadcom-soared-marvell-fell/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1935042488.USD","SG9999003800.SGD","LU0320765059.SGD","LU2271345857.HKD","ON","LU0314106906.USD","LU0994945656.USD","LU2552382215.SGD","BK4598","AVGOP","LU2491050154.USD","IE00B5949003.HKD","LU0096364046.USD","LU0312595415.SGD","IE00BMPRXR70.SGD","LU0823421416.USD","LU1267930730.SGD","LU0256863811.USD","LU0345774391.USD","IE00BHPRN162.USD","LU1934455194.USD","IE00B5TLWC47.USD","LU2097344431.USD","LU0211328371.USD","USAW.SI","LU0289960550.SGD","LU0348723411.USD","LU1242518931.SGD","LU1951198990.SGD","LU2191332357.HKD","SGXZ51526630.SGD","LU2357305700.SGD","BK4550","IE00B4JS1V06.HKD","AVGO","LU1861214812.USD","BK4596","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","BK4559","LU2462157665.USD","BK4532","LU0082616367.USD","USJW.SI","LU0980610538.SGD","LU2092627202.USD","LU0823421333.USD"],"gpt_icon":1},{"id":"2518953787","title":"BUZZ-Genmab falls after J&J Hexabody opt-out","url":"https://stock-news.laohu8.com/highlight/detail?id=2518953787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518953787?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:20","pubTimestamp":1741681247,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab falls after J&J Hexabody opt-out** Shares in Genmab GMAB.CO fall 5.4% after Johnson & Johnson JNJ.N opted out of further clinical development of the Hexabody-CD38 cancer drug on Monday** Van Lanschot Kempen says that Hexabody did not differentiate enough from Darzalex, the company's flagship drug, and neither Genmab nor J&J will take the project forward** While Kempen says \"the shares are now free to perform\" without this overhang, Jyske Bank does not expect a quick rebound but rather a slow regain of market confidence** Kempen expects continued earnings momentum and growing appreciation for another cancer drug Epkinly as a major growth driver** Genmab says J&J opt-out does not impact its 2025 guidance  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL8N3PU0BD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","IE00B3PB1722.GBP","LU2129689514.USD","LU1244550494.USD","BK4559","LU0640476718.USD","LU1059921491.USD","LU1280957306.USD","LU1935042991.SGD","BK4592","IE00B7SZLL34.SGD","IE00BVYPNV92.GBP","BK4585","SG9999001440.SGD","IE0002141913.USD","LU0289739699.SGD","LU1023059063.AUD","LU1718418525.SGD","LU2505996509.AUD","LU0058720904.USD","BK4532","LU1074936037.SGD","LU1261432733.SGD","IE000M9KFDE8.USD","LU0466842654.USD","LU2129689605.HKD","LU1267930813.SGD","IE0009355771.USD","JNJ","LU1066051498.USD","SG9999002232.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU2430703095.HKD","BK4007","LU1221951129.SGD","IE00BDGV0183.EUR","IE00BGHQF631.EUR","LU0234570918.USD","LU2430703251.USD","LU0889566641.SGD","LU0122379950.USD","LU2592432038.USD","IE00B19Z3B42.SGD","LU0792757196.USD","BK4534","LU1244550221.USD","LU2133065610.SGD","LU2505996681.GBP","LU0203345920.USD"],"gpt_icon":0},{"id":"2518980747","title":"The Nasdaq Just Plunged 728 Points: 3 Must-See Statistics That Put This Move Into Perspective","url":"https://stock-news.laohu8.com/highlight/detail?id=2518980747","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518980747?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:06","pubTimestamp":1741680360,"startTime":"0","endTime":"0","summary":"Investor perspective changes everything on Wall Street.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/11/nasdaq-plunged-728-points-3-must-see-statistics/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IVV","BK4550","NQmain","TQQQ","IE00BKPKM429.USD",".SPX","NDAQ","SDS","QID","BK4504","BK4585","IE00BGHQF748.EUR","BK4534","SH","SPXU","SSO","UPRO","IE00B64PRP62.GBP","VOO","BK4559","LU2210150020.SGD","BK4588","ESmain","PSQ","BK4112","MNQmain","SQQQ","BK4581","BK4122","TSYW.SI","QLD","OEF",".IXIC","OEX","USAW.SI","PCOM","LU2210149790.SGD","NVIW.SI","SPY","USJW.SI","LU2095319765.USD","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2518297857","title":"Wall Street declines after new Trump tariffs on Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2518297857","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518297857?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:04","pubTimestamp":1741680257,"startTime":"0","endTime":"0","summary":"US stocks have opened lower as investors appeared spooked about tariff clashes and the state of the country's economy.","market":"nz","thumbnail":"https://images.thewest.com.au/publication/C-18007980/7c356af7212dc3719b8bd5a77aabff334d5ca9f5-16x9-x0y0w1280h720.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-18007980/7c356af7212dc3719b8bd5a77aabff334d5ca9f5-16x9-x0y0w1280h720.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/markets/wall-street-declines-after-new-trump-tariffs-on-canada-c-18007980","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/markets/wall-street-declines-after-new-trump-tariffs-on-canada-c-18007980","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["SSO","VOO","OEX","SPY","IVV","BK4585","BK4581","BK4559","BK4550","UPRO",".SPX","SH","SPXU","ESmain","SDS","BK4504","OEF","BK4534","BK4588"],"gpt_icon":0},{"id":"2518985407","title":"2seventy Bio to be Acquired by Bristol Myers Squibb","url":"https://stock-news.laohu8.com/highlight/detail?id=2518985407","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518985407?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:03","pubTimestamp":1741680222,"startTime":"0","endTime":"0","summary":"2seventy Bio  said late Monday that it has agreed to be acquired by Bristol Myers Squibb  for a price of $5 per share in an all-cash deal valuing the company at about $286 million.The price represents an 88% premium over the March 7 closing price of $2.66 per share, the multiple myeloma-focused biotech company said.2seventy bio said its board has unanimously recommended the deal to shareholders, some of which already agreed to tender their shares in support of the acquisition.The transaction is expected to close in Q2, after which 2seventy bio's shares will no longer be listed for trading on Nasdaq, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4559","IE00BFTCPJ56.SGD","LU2133065610.SGD","BK4534","LU1323610961.USD","LU1868837136.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU1670710588.SGD","IE00BJJMRZ35.SGD","BK4007","LU1670711123.USD","LU1093756325.SGD","BK4588","LU0882574055.USD","LU0321505868.SGD","LU2242646821.SGD","LU0456855351.SGD","LU0061475181.USD","IE00B2B36J28.USD","LU0868494617.USD","LU1571399168.USD","LU2242652126.USD","BMY","LU0306806265.USD","BK4126","LU1585245621.USD","LU1868836591.USD","LU1670711040.USD","LU1868836757.USD","LU1989771016.USD","LU1261432733.SGD","LU1430594728.SGD","BK4585","LU1074936037.SGD","MYE","LU0225284248.USD","LU0237698245.USD","BK4532","LU0096364046.USD","LU1670710661.SGD","LU0306807586.USD","IE0002141913.USD","LU2360032135.SGD","LU1093756168.USD","LU1868836914.USD","IE00BSNM7G36.USD","TSVT","LU1291159041.SGD","LU1032466523.USD"],"gpt_icon":0},{"id":"2518762071","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518762071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518762071?lang=en_us&edition=fundamental","pubTime":"2025-03-11 15:31","pubTimestamp":1741678265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BridgeBio Pharma (BBIO – Research Report), Johnson...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-bridgebio-pharma-bbio-johnson-johnson-jnj-and-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-bridgebio-pharma-bbio-johnson-johnson-jnj-and-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930813.SGD","IE00BVYPNV92.GBP","LU1935042991.SGD","LU0234570918.USD","LU1162221912.USD","IE00BJT1NW94.SGD","LXRX","IE0002141913.USD","LU0889566641.SGD","LU0792757196.USD","LU0795875086.SGD","BK4559","LU0114720955.EUR","LU2129689514.USD","LU2430703251.USD","IE00BDGV0183.EUR","BK4534","LU0345770308.USD","BK4533","JNJ","IE0034235303.USD","LU1023059063.AUD","LU1059921491.USD","LU2430703095.HKD","BK4139","LU1674673691.USD","LU0234572021.USD","BBIO","LU0882574055.USD","IE00B3PB1722.GBP","LU1914381329.SGD","HCSG","SG9999002232.USD","LU1066053197.SGD","LU1280957306.USD","BK4585","BK4550","IE00B19Z3B42.SGD","LU1894683348.USD","LU1778281490.HKD","LU0098860793.USD","LU1244550577.SGD","IE00B4R5TH58.HKD","BK4504","LU1718418525.SGD","BK4007","LU1732800096.USD","BK4581","LU1261432733.SGD","LU0345769631.USD"],"gpt_icon":0},{"id":"2518628507","title":"CORRECTED-ANALYSIS-If Europe builds the gigafactories, will an AI industry come?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518628507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518628507?lang=en_us&edition=fundamental","pubTime":"2025-03-11 15:30","pubTimestamp":1741678200,"startTime":"0","endTime":"0","summary":"Corrects description of CBRE in paragraph 11, to real estate consultancy, not data centre consultancyEU plan to build AI gigafactories faces challenges on chip supply and electricityHope is to build domestic AI in line with European rulesConcerns over entering AI spending race and short lifespan of data centresUS currently limiting access to AI chips neededBy Toby Sterling. AMSTERDAM, March 11  - The European Commission is raising $20 billion to construct four \"AI gigafactories\" as part of Europe's strategy to catch up with the U.S. and China on artificial intelligence, but some industry experts question whether it makes sense to build them. The plan for the large public access data centres, unveiled by European Commission President Ursula von der Leyen last month, will face challenges ranging from obtaining chips to finding suitable sites and electricity. \"Even if we would build such a big computing factory in Europe, and even if we would train a model on that infrastructure, once it'","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL6N3PP0SG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","NVD2.UK","LU0109392836.USD","SG9999014567.USD","LU2087625088.SGD","USAW.SI","SG9999014914.USD","NVDS.UK","LU0289941410.SGD","SNVD.UK","IE0034235303.USD","LU0061474705.USD","BK4608","CBRE","NVDS","SG9999014575.USD","NVD3.UK","LU2462157665.USD","LU1935042488.USD","3NVD.UK","LU2092937148.SGD","LU2275660780.HKD","NVDY","LU2592432038.USD","BK4532","SGXZ81514606.USD","BK4559","2NVD.UK","LU1084165304.USD","LU2294711713.HKD","LU1633808545.USD","LU2452424414.USD","LU0256863811.USD","LU1066053197.SGD","LU2413666426.HKD","NVDA","LU0289961442.SGD","LU2750360997.AUD","BK4503","NVDD","NVDU","BK4538","LU1721428933.USD","LU0097036916.USD","LU1642822529.SGD"],"gpt_icon":1},{"id":"2518576397","title":"ASX 200 crash playbook, pause or panic?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518576397","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518576397?lang=en_us&edition=fundamental","pubTime":"2025-03-11 14:08","pubTimestamp":1741673337,"startTime":"0","endTime":"0","summary":"Ahhh the stock market. Usually, a placid and reliable money maker…yet every now and then it’s more like the Naked Gun movie scene where Frank Drebin is waving along the public in front of the fireworks factory…There’s nothing to see here…The present fireworks equate to the sharp falls  in stock prices as investors grapple with the big Trump unknown. The returning US president’s trade policies have rattled markets, which to be fair, were probably on the back foot anyway as economic growth cooled in the face of inflation-driven cost of living pressures.President Trump’s trade war threatens to reignite inflationary pressures and pile even greater hardship on households at a time where his Department of Government Efficiency  initiative, led by flamboyant billionaire Elon Musk, has already resulted in significant layoffs and slashed public spending.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/asx-200-crash-playbook-pause-or-panic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/asx-200-crash-playbook-pause-or-panic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK4534","BK4581","BK4504","OEF","ESmain",".SPX","SPY","NVIW.SI","UPRO",".IXIC","SPXU","VOO","BK4550","MNQmain","SH","QID","QQQ","BK4588","SDS","QLD","SSO","USJW.SI","TSYW.SI","SQQQ","OEX","IVV","BK4559","NQmain","TQQQ","USAW.SI","BK4585","PSQ"],"gpt_icon":1},{"id":"2518755169","title":"Ninety-nine red flags","url":"https://stock-news.laohu8.com/highlight/detail?id=2518755169","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518755169?lang=en_us&edition=fundamental","pubTime":"2025-03-11 12:17","pubTimestamp":1741666650,"startTime":"0","endTime":"0","summary":"This is causing a huge rethink on US growth prospects and the implications for equities and interest rates. Markets have also been blindsided by Europe’s response to the seismic shift in the global security landscape. After the Berlin Wall fell, German borrowing costs soared. Now the US is walking away from NATO, German borrowing costs are soaring. It’s hard to make sense of it all when markets are re-pricing quickly. My sense is that geopolitical changes will get priced into bond markets more quickly than in credit and equities. One thing is for sure, political risk is not going away and political risk means market volatility.These political developments are of historical importance. They have been prompted of course by the ongoing Ukraine conflict, and by the stance of the US Trump Administration. Washington has signalled the US is no longer willing to shoulder what it sees as an unfair burden - providing global economic security by playing the role of consumer of last resort, and pl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/ninety-nine-red-flags","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/ninety-nine-red-flags","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["SH","ESmain","BK4550","BK4534","BK4588","OEF","SSO","OEX","BK4156","BK4585","BK4559",".SPX","BK4504","UPRO","SPXU","VOO","IVV","SPY","BK4581","SDS"],"gpt_icon":0},{"id":"2518732041","title":"BRIEF-2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2518732041","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518732041?lang=en_us&edition=fundamental","pubTime":"2025-03-11 10:20","pubTimestamp":1741659625,"startTime":"0","endTime":"0","summary":"BRIEF-2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per ShareMarch 10 (Reuters) - 2Seventy Bio Inc TSVT.O:2SEVENTY BIO ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nTUA4LTMKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","LU1585245621.USD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU1261432733.SGD","IE0002141913.USD","LU0985481810.HKD","BK4559","LU1430594728.SGD","IE00BFXG1179.USD","LU1670710661.SGD","LU1032466523.USD","LU2242646821.SGD","BK4534","LU0868494617.USD","LU1093756168.USD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU1670711040.USD","TSVT","LU0096364046.USD","LU1989771016.USD","LU2242652126.USD","LU1868837136.USD","BK4588","LU0882574055.USD","LU1074936037.SGD","LU1291159041.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU2125154935.USD","IE00BSNM7G36.USD","LU1868837300.USD","LU0061475181.USD","LU0237698245.USD","LU0306807586.USD","LU1323610961.USD","BK4585","BK4532","LU1571399168.USD","LU1868836757.USD","LU2133065610.SGD","LU0225284248.USD","LU1718418525.SGD","BK4007","BK4581","BMY","LU0225771236.USD","LU2125154778.USD"],"gpt_icon":0},{"id":"2518375950","title":"2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb","url":"https://stock-news.laohu8.com/highlight/detail?id=2518375950","media":"Business Wire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518375950?lang=en_us&edition=fundamental","pubTime":"2025-03-11 10:17","pubTimestamp":1741659420,"startTime":"0","endTime":"0","summary":"Expected to close in the second quarter of 2025, subject to customary closing conditions. \"A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders,\" said Chip Baird, chief executive officer, 2seventy bio. \"The strategic rationale for this acquisition is clear and today’s announcement represents the culmination of the journey for 2seventy bio. We believe that Abecma will continue to benefit from BMS’ experience and resources to ensure this important therapy is delivered to patients who need it. I would like to express my deep gratitude for current and past 2seventy team members and more broadly the dedicated community of patients, scientists, providers and partners that helped take cell and gene therapy from a complicated idea to reality for patients.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/2seventy-bio-enters-definitive-agreement-021700617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4581","LU1868836914.USD","BMY","LU2125154778.USD","LU0882574055.USD","LU1718418525.SGD","LU0061475181.USD","BK4532","TSVT","LU0114720955.EUR","LU2065731478.USD","LU1868836757.USD","BK4086","BK4006","LU1543694498.USD","LU0985481810.HKD","LU0306807586.USD","LU0868494617.USD","MAS","IE0002141913.USD","IE00B19Z4B17.USD","IE0031619046.USD","LU1596574779.USD","LU1670711123.USD","LU2360032135.SGD","LU0321505439.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0170899867.USD","LU2413665964.HKD","LU1620156213.USD","LU1093756325.SGD","LU2413666004.HKD","BK4007","LU2242646821.SGD","LU1868836591.USD","CAR","CRS","LU1093756168.USD","BK4230","BK4559","LU1323610961.USD","IE00BFXG1179.USD","LU0321505868.SGD","LU1032466523.USD","IE00B2B36J28.USD","LU1670711040.USD","LU0225284248.USD","IE00B7SZL793.SGD","MYE"],"gpt_icon":0},{"id":"2518755223","title":"Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2518755223","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518755223?lang=en_us&edition=fundamental","pubTime":"2025-03-11 10:00","pubTimestamp":1741658442,"startTime":"0","endTime":"0","summary":"Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.Imagine yourself as a passive income investor looking for a medical stock with significant share growth potential. Wall Street analysts with JP Morgan, Citi, and Evercore ISI would recommend looking at Merck & Co , which they've all given a \"buy\" rating. It may also have as much as 82% upside. Keep reading to learn why this medical stock could be right up your alley.A recent profile of Merck by Barchart showed that 18 of the 25 analysts offering opinions have given the company a \"strong-buy\" rating. Their average price target for Merck was $122.55. The most bullish projection for Merck's stock price from Barchart analysts sees the company stock reaching $168. That means Merck could have up to 82% upside on the current","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wall-street-analysts-think-medical-020042123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0965509010.AUD","LU1037948897.HKD","MRK","SG9999014542.SGD","LU0203345920.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0861579265.USD","LU1989772840.SGD","LU2023250504.SGD","LU1057294990.SGD","IE00BLSP4239.USD","BK4559","LU1430594728.SGD","LU2089984988.USD","LU1989772923.USD","LU1941712348.USD","SGXZ57979304.SGD","LU0058720904.USD","SG9999014559.SGD","LU1023059063.AUD","LU2324357040.USD","LU2023250843.SGD","SG9999015358.SGD","SG9999001176.USD","LU0234572021.USD","LU1941712264.USD","SG9999001176.SGD","BK4588","LU0211331839.USD","LU1066051498.USD","IE0009355771.USD","IE00B2B36J28.USD","LU1069347547.HKD","LU1291159041.SGD","BK4516","LU1917777945.USD","SG9999013999.USD","LU0985320562.USD","SG9999002232.USD","BK4585","LU2461242641.AUD","LU1571399168.USD","LU2361044949.HKD","LU1974910355.USD","LU1061106388.HKD","IE00BN8TJ469.HKD","LU1066051225.USD","LU1035773651.USD","LU0238689110.USD"],"gpt_icon":0},{"id":"2518178020","title":"Nasdaq Correction: Is This High-Yield Dividend Stock the Right Place to Run for Cover?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518178020","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518178020?lang=en_us&edition=fundamental","pubTime":"2025-03-11 08:00","pubTimestamp":1741651200,"startTime":"0","endTime":"0","summary":"The Nasdaq has fallen into correction territory and is down more than 10%.Stock markets rise and fall over time. It's just how the markets work. But just as predictable as the pendulum swing from bull to bear  is, so too are the emotional swings that investors go through. Right now, investors are clearly selling assets, but they are also looking for a new home for the cash that's raised. One beneficiary has been high-yielding Kraft Heinz . Is that the right place to run for cover?Clearly, investors have shifted to a risk-off mentality. But here's the thing: You shouldn't sell indiscriminately, and you shouldn't buy that way, either.Kraft Heinz's dividend yield is around 5% compared to the consumer staples average of roughly 2.6%. It has a higher yield for a reason. Kraft Heinz's business hasn't been performing all that well. This isn't a new trend -- the company has been facing headwinds since Kraft and Heinz tied the knot several years ago.The original goal of the merger was to cut co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/10/nasdaq-correction-is-this-high-yield-dividend-stoc/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["MNQmain","BK4504","BK4212","PSQ","LU0070302665.USD","KHC","USAW.SI","US10Y.BOND","LU0162691827.USD","BK4112","QID","NQmain","LU2095319765.USD","TSYW.SI","US6M.BOND","LU0006061336.USD","BK4588",".IXIC","SQQQ","BK4558","LU0211331839.USD","US7Y.BOND","LU2210149790.SGD","TQQQ","IE00BKPKM429.USD","LU2210150020.SGD","NDAQ","BK4585","QLD","LU0225284248.USD","BK4559","LU0208291251.USD","LU0320765489.SGD","IE00BGHQF748.EUR","LU1699723380.USD","US30Y.BOND","NVIW.SI","USJW.SI","US12M.BOND","US3Y.BOND","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0225771236.USD","LU1571399168.USD","US5Y.BOND","US2Y.BOND","LU0985481810.HKD","LU0072461881.USD"],"gpt_icon":1},{"id":"2518780289","title":"Lam Research Corporation (LRCX): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2518780289","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518780289?lang=en_us&edition=fundamental","pubTime":"2025-03-11 07:36","pubTimestamp":1741649812,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds.In this article, we are going to take a look at where Lam Research Corporation  stands against the other oversold blue chip stocks.As per Franklin Templeton, the US equities have managed to provide strong gains over the past few years, with the S&P 500 repeatedly touching record highs, thanks to the Magnificent Seven’s dominance in AI. Despite elevated valuations, the broader market outlook is positive. Innovation and investment continue at a pace, sales growth has been accelerating, and earnings are expected to see a double-digit rise this year. Also, the US economy has a more business-friendly administration. That being said, there are risks, mainly related to the US trade policy and the expected impact of tariffs on critical sectors, including technology.Amidst such uncertainties, Franklin Templeton believes that investor confidence in the US equities is expected to remain strong. While t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lam-research-corporation-lrcx-hedge-233652867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","LU0061474960.USD","LU1069347547.HKD","USJW.SI","BK4559","LRCX","LU0157215616.USD","LU1366333091.USD","LU2106854487.HKD","BK4147","LU0719512351.SGD","BK4567","LU0348723411.USD","LU1917777945.USD","IE0009356076.USD","NQmain","LU0444971666.USD","IE00B7KXQ091.USD","IE00BQXX3D17.EUR","QID","IE00BFSS7M15.SGD","PSQ","LU0061475181.USD","VOO","QLD","BK4543",".IXIC","LU0096362180.USD","BK4533","IE00B775H168.HKD","NVIW.SI","TQQQ","LU0957791311.USD","BK4581","LU1974910355.USD","IE00BQXX3F31.USD","LU0476273544.USD","LU1670627923.USD","LU2023250504.SGD","BK4551","BK4585","LU0444973449.USD","MNQmain","IE0004445015.USD","SQQQ","BK4588","IE00BFSS8Q28.SGD","USAW.SI","LU1642822529.SGD"],"gpt_icon":1}],"pageSize":16,"totalPage":97,"pageCount":9,"totalSize":1551}]}}